Chemistry

Applications and Significance of Quantitative Structure–Activity Relationship (QSAR) in Rational Molecular Design: A Review

Vineeta Asati1, Varsha Nigam1, Mehzish Ahmed2, V. Abhishek2, Shweta Sharma2, Neelu Singh3

1Sanjeev Agrawal Global Educational (SAGE) University, Bhopal, Madhya Pradesh, India

2Career College (Autonomous), Bhopal, Madhya Pradesh, India

3Sagar Institute of Research and Technology – Excellence, Bhopal, Madhya Pradesh, India

Published November 2026

Abstract

Understanding how molecular structure governs biological activity is fundamental to rational drug discovery and predictive toxicology. While a qualitative evaluation of structural fragments influencing biological response is termed Structure-Activity Relationship (SAR), expressing these correlations mathematically produces a Quantitative Structure-Activity Relationship (QSAR). QSAR establishes a statistically significant mathematical link between the biological activity of a congeneric series of compounds and their physicochemical or structural descriptors. As a cornerstone of Computer-Aided Drug Design (CADD), QSAR enables the in silico prediction of pharmacological potency, pharmacokinetic profiles, and toxicological endpoints. This review outlines the historical evolution, multidimensional classifications (1D to 6D), key physicochemical parameters, statistical modeling algorithms, and validation criteria of QSAR methodologies in modern molecular design.

Keywords: QSAR; computer-aided drug design (CADD); 3D-QSAR; CoMFA; CoMSIA; physicochemical descriptors; chemometrics

1Introduction

Explaining the relationship between chemical architecture and biological response is a primary objective in medicinal chemistry and molecular design. A qualitative assessment of how specific pharmacophoric fragments or substructures modulate biological effects is known as Structure-Activity Relationship (SAR), which forms the conceptual basis of Computer-Aided Drug Design (CADD). When these structural features are quantified using numerical descriptors and correlated mathematically with biological endpoints, the methodology advances to Quantitative Structure-Activity Relationship (QSAR).

The fundamental premise of QSAR is that the molecular structure of a compound dictates its physicochemical properties and chemical reactivity, which in turn govern its biological and toxicological behavior [1, 2]. These molecular descriptors—quantifying hydrophobicity, topology, electronic distribution, and steric bulk—are derived either empirically or computationally. Beyond accelerating lead optimization, robust QSAR models significantly reduce development costs and minimize reliance on in vivo animal testing [3, 4].

1.1Historical evolution of QSAR

The conceptual origins of QSAR date back to the late 19th century, evolving into a rigorous computational discipline over the following decades:

2Classification of QSAR methodologies

Based on the dimensionality of the molecular descriptors utilized, QSAR methodologies are categorized into six distinct classes (Table 1).

Table 1. Classification of QSAR methodologies.
Dimensionality Description and parameters used
1D-QSAR Correlates biological activity with global, bulk molecular properties and constitutional descriptors (e.g., molecular weight, pKa, log P).
2D-QSAR Incorporates two-dimensional structural topology, connectivity indices, and physicochemical parameters without considering spatial orientation.
3D-QSAR Correlates biological activity with non-covalent interaction fields (steric, electrostatic, hydrophobic) surrounding the 3D conformation of aligned ligands.
4D-QSAR Incorporates conformational flexibility and ensemble sampling of ligand–receptor binding modes alongside 3D spatial properties.
5D-QSAR Accounts for receptor flexibility by explicitly modeling multiple induced-fit conformations within the 4D-QSAR framework.
6D-QSAR Integrates different solvation models and desolvation energy profiles into 5D-QSAR to simulate physiological environments accurately.

2.1Advances in 3D-QSAR

3Core physicochemical parameters in QSAR

In classical Hansch analysis, biological activity is expressed as a linear or parabolic function of three primary physicochemical parameters [1, 2], as shown in Equation (1), or, for hydrophobicity, in the parabolic form of Equation (2):

log ( 1 / C ) = a π + b σ + c E s + d (1)
log ( 1 / C ) = − k 1 ( log P ) 2 + k 2 ( log P ) + k 3 (2)

where C is the molar concentration required to elicit a standard biological response, π denotes hydrophobicity, σ represents electronic effects, Es signifies steric factors and a, b, c and d are regression coefficients.

3.1Hydrophobicity (log P and π)

Hydrophobicity governs the ability of a drug molecule to partition from an aqueous phase across lipophilic biological membranes to reach its target receptor.

P = [ D r u g ] o c t a n o l [ D r u g ] a q u e o u s (3)
π X = log P X − log P H (4)

3.2Electronic effects (σ)

Electronic properties dictate the ionization state (pKa) and polarity of a molecule, critically influencing both membrane permeability and electrostatic drug–receptor interactions.

σ X = log K X − log K H (5)

Note: Classical Hammett constants are inapplicable to ortho-substituents due to steric interference near the reaction center, requiring specialized treatments such as Fujita–Nishioka analysis [8, 9].

3.3Steric effects (Es)

Steric parameters, such as Taft's steric factor (Es) or molar refractivity (MR), quantify the bulk, size, and spatial geometry of substituents. Complementary steric fit between the ligand and the receptor's active site is essential for optimal binding affinity.

3.4Craig plot

A Craig plot is a two-dimensional graphical optimization tool plotting the Hammett electronic parameter (σ) on the x-axis against the hydrophobic parameter (π) on the y-axis. It partitions substituents into four quadrants (+π/+σ, +π/-σ, -π/+σ, -π/-σ), enabling medicinal chemists to systematically select substituents that independently modulate electronic and lipophilic properties.

4QSAR workflow and statistical modelling algorithms

4.1Standard QSAR workflow

Developing a predictive QSAR model follows a structured five-stage pipeline [3, 9]:

  1. 1. Data Curation & Structure Generation: Compilation of reliable biological assay data and generation of 1D, 2D, or 3D molecular structures.
  2. 2. Descriptor Calculation: Computation of constitutional, topological, electronic, geometric, and quantum-chemical descriptors.
  3. 3. Data Pre-processing: Normalization, standardization, removal of collinear or zero-variance variables, feature selection, and outlier detection.
  4. 4. Multivariate Statistical Modeling: Establishing mathematical correlations between selected descriptors and biological activity.
  5. 5. Model Validation: Internal and external statistical evaluation using metrics such as correlation coefficient (R), coefficient of determination (R2), cross-validated correlation coefficient (Q2), Mean Squared Error (MSE), and Root Mean Squared Error (RMSE) [3].

4.2Regression and machine learning algorithms

5OECD principles for QSAR validation and applications

To ensure regulatory acceptance and scientific reliability (per OECD guidelines), a valid QSAR model must satisfy five core criteria [3]:

  1. 1. A defined endpoint: A clear, standardized biological or physicochemical measurement.
  2. 2. An unambiguous algorithm: A transparent and reproducible mathematical formulation.
  3. 3. A defined domain of applicability: The defined chemical space within which model predictions are statistically reliable.
  4. 4. Appropriate measures of goodness-of-fit, robustness, and predictivity: Rigorous internal cross-validation (Q2) and external test-set validation (R2pred).
  5. 5. A mechanistic interpretation: Establishing a plausible biochemical or physicochemical rationale, wherever possible.

5.1Key applications

6Conclusion

Quantitative Structure-Activity Relationship (QSAR) modeling has matured from classical linear free energy correlations into an indispensable, multidimensional discipline within modern computational chemistry, drug discovery, and regulatory toxicology [1, 3, 6]. By translating complex molecular architectures into quantifiable physicochemical and spatial descriptors, QSAR enables researchers to predict biological potency, optimize pharmacokinetic profiles, and identify potential toxicological hazards prior to chemical synthesis [4, 7]. The progression from 1D and 2D descriptors to 3D–6D methodologies—such as CoMFA and CoMSIA—alongside advanced machine learning algorithms like SVM, ANN, and evolutionary regression techniques, has markedly improved the accuracy and applicability of predictive models across diverse chemical spaces [20, 22, 24]. Nevertheless, the reliability of any QSAR model remains fundamentally dependent on high-quality experimental data, rigorous feature selection, and strict adherence to OECD validation principles, particularly defining the domain of applicability [3]. As artificial intelligence, big data analytics, and molecular simulation continue to converge, QSAR will play an increasingly pivotal role in accelerating rational molecular design while substantially reducing development costs and animal testing.

References

  1. [1]Hansch C, Maloney PP, Fujita T, Muir RM. Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature. 1962;194(4824):178–180. https://doi.org/10.1038/194178b0
  2. [2]Hansch C, Fujita T. ρ-σ-π analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc. 1964;86(8):1616–1626. https://doi.org/10.1021/ja01062a035
  3. [3]Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci. 2003;22(1):69–77. https://doi.org/10.1002/qsar.200390007
  4. [4]Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol. 2006;3:11. https://doi.org/10.1186/1743-8977-3-11
  5. [5]Free SM Jr, Wilson JW. A mathematical contribution to structure–activity studies. J Med Chem. 1964;7(4):395–399. https://doi.org/10.1021/jm00334a001
  6. [6]Yap CW, Li ZR, Chen YZ. Quantitative structure–pharmacokinetic relationships for drug clearance by using statistical learning methods. J Mol Graph Model. 2006;24(5):383–395.
  7. [7]Zhao CY, Zhang HX, Zhang XY, Liu MC, Hu ZD, Fan BT. Application of support vector machine (SVM) for prediction toxic activity of different data sets. Toxicology. 2006;217(2–3):105–119.
  8. [8]Tsuno Y, Ibata T, Yukawa Y. Resonance effect in Hammett relationship. I. The substituent effect in the acid catalyzed decompositions of ω-diazoacetophenones in acetic acid. Bull Chem Soc Jpn. 1959;32(9):960–965.
  9. [9]Katritzky AR, Lobanov VS, Karelson M. Comprehensive descriptors for structural and statistical analysis (CODESSA) reference manual, version 2.7.10. Gainesville (FL): University of Florida; 2007.
  10. [10]Yuan YN, Zhang RS, Hu RJ, Ruan XF. Prediction of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas based on the heuristic method, support vector machine and projection pursuit regression. Eur J Med Chem. 2009;44(1):25–34.
  11. [11]Ma WP, Luan F, Zhao CY, Zhang XY, Liu MC, Hu ZD, et al. QSAR prediction of the penetration of drugs across a polydimethylsiloxane membrane. QSAR Comb Sci. 2006;25(10):895–904.
  12. [12]Luan F, Ma WP, Zhang XY, Zhang HX, Liu MC, Hu ZD, et al. Quantitative structure–activity relationship models for prediction of sensory irritants (log RD50) of volatile organic chemicals. Chemosphere. 2006;63(7):1142–1153.
  13. [13]Fisz JJ. Combined genetic algorithm and multiple linear regression (GA-MLR) optimizer: Application to multi-exponential fluorescence decay surface. J Phys Chem A. 2006;110(48):12977–12985.
  14. [14]Wold H. Estimation of principal components and related models by iterative least squares. In: Krishnaiah PR, editor. Multivariate analysis. New York: Academic Press; 1966. p. 391–420.
  15. [15]Jöreskog KG, Wold H. Systems under indirect observation: Causality, structure, prediction. Amsterdam: North-Holland; 1982.
  16. [16]Yin PY, Mohemaiti P, Chen J, Zhao XJ, Lu X, Yimiti A, et al. Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry. J Chromatogr B. 2008;871(2):322–327.
  17. [17]Niazi A, Jafarian B, Ghasemi J. Kinetic spectrophotometric determination of trace amounts of palladium by whole kinetic curve and a fixed time method using resazurine sulfide reaction. Spectrochim Acta A. 2008;71(3):841–846.
  18. [18]Niazi A, Amjadi E, Nori-Shargh D, Bozorghi SJ. Simultaneous voltammetric determination of lead and tin by adsorptive differential pulse stripping method and orthogonal signal correction-partial least squares in water samples. J Chin Chem Soc. 2008;55(2):276–285.
  19. [19]Luan F, Liu HT, Wen YY, Zhang XY. Prediction of quantitative calibration factors of some organic compounds in gas chromatography. Analyst. 2008;133(7):881–887.
  20. [20]Chen HF. Quantitative predictions of gas chromatography retention indexes with support vector machines, radial basis neural networks and multiple linear regression. Anal Chim Acta. 2008;609(1):24–36.
  21. [21]Yuan YN, Zhang RS, Hu RJ, Ruan XF. Prediction of volatile components retention time in blackstrap molasses by least-squares support vector machine. QSAR Comb Sci. 2008;27(5):535–542.
  22. [22]Si HZ, Zhang KJ, Hu ZD, Fan BT. QSAR model for prediction capacity factor of molecular imprinting polymer based on gene expression programming. QSAR Comb Sci. 2007;26(1):41–50.
  23. [23]Friedman JH, Stuetzle W. Projection pursuit regression. J Am Stat Assoc. 1981;76(376):817–823. https://doi.org/10.1080/01621459.1981.10477729
  24. [24]Gunturi SB, Archana K, Khandelwal A, Narayanan R. Prediction of hERG potassium channel blockade using kNN-QSAR and local lazy regression methods. QSAR Comb Sci. 2008;27(11–12):1305–1317.
  25. [25]Guha R, Dutta D, Jurs PC, Chen T. Local lazy regression: Making use of the neighborhood to improve QSAR predictions. J Chem Inf Model. 2006;46(4):1836–1847. https://doi.org/10.1021/ci060064e
  26. [26]Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627. https://doi.org/10.1126/science.1114397
  27. [27]Chatterjee R. The challenge of regulating nanomaterials. Environ Sci Technol. 2008;42(2):339–343.
  28. [28]Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol. 2004;22(1):47–52. https://doi.org/10.1038/nbt927
  29. [29]Chen FQ, Gerion D. Fluorescent CdSe/ZnS nanocrystal–peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett. 2004;4(10):1827–1832.
  30. [30]Zhou K, Wang R, Xu B, Li Y. Synthesis, characterization and catalytic properties of CuO nanocrystals with various shapes. Nanotechnology. 2006;17(15):3939–3943.
  31. [31]Yuranova T, Laub D, Kiwi J. Synthesis, activity and characterization of textiles showing activity under daylight irradiation. Catal Today. 2007;122(1–2):109–117.